References
- VolkmanAGowansJLThe Origin of Macrophages from Bone Marrow in the RatBr J Exp Pathol196546627014295560
- Burke B; SumnerSMaitlandNLewisCEMacrophages in gene therapy: cellular delivery vehicles and in vivo targetsJ Leukoc Biol9200272341742812223508
- PasslickBFliegerDZiegler-HeitbrockHWIdentification and characterization of a novel monocyte subpopulation in human peripheral bloodBlood1989747252725342478233
- WeberCBelgeKUvon HundelshausenPDifferential chemokine receptor expression and function in human monocyte subpopulationsJ Leukoc Biol20006769970410811011
- RandolphGJSanchez-SchmitzGLiebmanRMSchakelKThe CD16(+) (FcgammaRIII(+)) subset of human monocytes preferentially becomes migratory dendritic cells in a model tissue settingJ Exp Med200219651752712186843
- SerbinaNVSalazar MatherTPBironCAKuzielWAPamerEGTNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infectionImmunity72003191597012871639
- BadylakSFGilbertTWImmune Response to Biologic Scaffold MaterialsSemin Immunol200820210911618083531
- MantovaniASozzaniSLocatiMAllavenaPSicaAMacrophage polarization: tumor associated macrophages as a paradigm for polarized M2 mononuclear phagocytesTrends Immunol2002231154955512401408
- BalkwillFCharlesKAMantovaniASmoldering and polarized inflammation in the initiation and promotion of malignant diseaseCancer Cell20057321121715766659
- LebreMCTakPPMacrophage Subsets in Immune-Mediated Inflammatory Disease: Lessons from Rheumatoid Arthritis, Spondyloarthritis, Osteoarthritis, Behçet’s Disease and GoutThe Open Arthritis Journal201031823
- GerlagDMTakPPNovel approaches for the treatment of rheumatoid arthritis: lessons from the evaluation of synovial biomarkers in clinical trialsBest Pract Res Clin Rheumatol200822231132318455687
- Van der HeijdeDMvan’t HofMAvan RielPLJudging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity scoreAnn Rheum Dis199049119169202256738
- MulherinDFitzGeraldOBresnihanBSynovial tissue macrophage populations and articular damage in rheumatoid arthritisArthritis Rheum19963911151248546720
- TakPPBresnihanBThe pathogenesis and prevention of joint damage in rheumatoid arthritis: advances from synovial biopsy and tissue analysis [review]Arthritis Rheum200043122619263311145019
- HamiltonJATakPPThe Dynamics of Macrophage Lineage Populations in Inflammatory and Autoimmune DiseasesArthritis Rheum20096051210122119404968
- AmbarusCAKrauszSvan EijkMSystematic validation of specific phenotypic markers for in vitro polarized human macrophagesJ Immunol Methods20113751–219620622075274
- LiJHsuHCMountzJDManaging Macrophages in Rheumatoid Arthritis by Reform or RemovalCurr Rheumatol Rep201214544545422855296
- BleesingJPradaASiegelDMThe diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritisArthritis Rheum200756396597117328073
- DennisGJrHolwegCTKummerfeldSKSynovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeuticsArthritis Res Ther2014162R9025167216
- MaruottiNAnneseTCantatoreFPRibattiDMacrophages and angiogenesis in rheumatic diseasesVasc Cell2013511123725043
- ByrneJCNí GabhannJLazzariEGenetics of SLE: functional Relevance for Monocytes/Macrophages in diseaseClin Dev Immunol2012201258235223227085
- KavaiMSzegediGImmune complex clearance by monocytes and macrophages in systemic Lupus erythematosusAutoimmun Rev20076749750217643939
- SestakALFürnrohrBGHarleyJBMerrillJTNamjouBThe genetics of systemic Lupus erythematosus and implications for targeted therapyAnn Rheum Dis201170Suppl1i37i4321339217
- AkiraSUematsuSTakeuchiOPathogen recognition and innate immunityCell2006124478380116497588
- LafyatisRMarshak-RothsteinAToll-like receptors and innate immune responses in systemic lupus erythematosusArthritis Res Ther20079622218086320
- Marshak-RothsteinAToll-like receptors in systemic autoimmune diseaseNat Rev Immunol200661182383517063184
- LauCMBroughtonCTaborASRNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagementJ Exp Med200520291171117716260486
- LeadbetterEARifkinIRHohlbaumAMChromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptorsNature2002416688160360711948342
- BanchereauJPascualVType I interferon in systemic lupus erythematosus and other autoimmune diseasesImmunity200625338339216979570
- WermelingFChenYPikkarainenTClass A scavenger receptors regulate tolerance against apoptotic cells, and autoantibodies against these receptors are predictive of systemic lupusJ Exp Med2007204102259226517893199
- MartinFKearneyJFMarginal-zone B cellsNat Rev Immunol20022532333512033738
- LiYLiHNiDWeigertMAnti-DNA B cells in MRL/lpr mice show altered differentiation and editing patternJ Exp Med2002196121543155212486097
- EnzlerTBonizziGSilvermanGJAlternative and classical NF-kappa B signaling retain autoreactive B cells in the splenic marginal zone and result in lupus-like diseaseImmunity200625340341516973390
- KraalGMebiusRNew insights into the cell biology of the marginal zone of the spleenInt Rev Cytol200625017521516861066
- RonnblomLElorantaMLAlmGVThe type I interferon system in systemic lupus erythematosusArthritis Rheum200654240842016447217
- SekiEDe MinicisSOsterreicherCHTLR4 enhances TGF-beta signaling and hepatic fibrosisNat Med200713111324133217952090
- SugiuraHIchikawaTKoaraiAActivation of Toll-like receptor 3 augments myofibroblast differentiationAm J Respir Cell Mol Biol200940665466218988918
- MeneghinAChoiESEvanoffHLTLR9 is expressed in idiopathic interstitial pneumonia and its activation promotes in vitro myofibroblast differentiationHistochem Cell Biol2008130597999218633634
- FisherERRodnanGPPathologic observations concerning the cutaneous lesion of progressive systemic sclerosis: an electron microscopic histochemical and immunohistochemical studyArthritis Rheum1960353654513699954
- MunderMEichmannKModolellMAlternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotypeJ Immunol199816011534753549605134
- PopeRMTschoppJThe Role of Interleukin-1 and the Inflammasome in Gout Implications for TherapyArthritis rheum200756103183318817907163
- MartinonFBurnsKTschoppJThe inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-Mol Cell200210241742612191486
- MartinonFTschoppJInflammatory caspases and inflammasomes: master switches of inflammationCell Death Differ2007141102216977329
- van KuijkAWReinders-BlankertPSmeetsTJDijkmansBATakPPDetailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatmentAnn Rheum Dis200665121551155716728461
- BuechlerCRitterMOrsoELangmannTKluckenJSchmitzGRegulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuliJ Leukoc Biol20006719710310648003
- SulahianTHHoggerPWahnerAEHuman monocytes express CD163, which is upregulated by IL-10 and identical to p155Cytokine20001291312132110975989
- BaetenDDemetterPCuvelierCAMacrophages expressing the scavenger receptor CD163: a link between immune alterations of the gut and synovial inflammation in spondyloarthropathyJ Pathol2002196334335011857499
- BaetenDKruithofEDeRLDiagnostic classification of spondylarthropathy and rheumatoid arthritis by synovial histopathology: a prospective study in 154 consecutive patientsArthritis Rheum20045092931294115457462
- VandoorenBNoordenbosTAmbarusCAbsence of a classically activated macrophage cytokine signature in peripheral spondylarthritis, including psoriatic arthritisArthritis Rheum200960496697519333931
- WargerTHilfNRechtsteinerGInteraction of TLR2 and TLR4 ligands with the N-terminal domain of Gp96 amplifies innate and adaptive immune responsesJ Biol Chem200628132225452255316754684
- FernandesJCMartel-PelletierJPelletierJPThe role of cytokines in osteoarthritis pathophysiologyBiorheology2002391–223724612082286
- Martel-PelletierJPathophysiology of osteoarthritisOsteoarthritis Cartilage200412Suppl AS31S3314698638
- PelletierJPMartel-PelletierJAbramsonSBOsteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targetsArthritis Rheum20014461237124711407681
- BenitoMJVealeDJFitzGeraldOvan den BergWBBresnihanBSynovial tissue inflammation in early and late osteoarthritisAnn Rheum Dis20056491263126715731292
- FarahatMNYanniGPostonRPanayiGSCytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritisAnn Rheum Dis199352128708758311538
- ClarkAGJordanJMVilimVSerum cartilage oligomeric protein reflects osteoarthritis presence and severity: the Johnston County Osteoarthritis ProjectArthritis Rheum199942112356236410555031
- SowersMJannauschMSteinEJamadarDHochbergMLachanceLC-reactive protein as a biomarker of emergent osteoarthritisOsteoarthritis Cartilage200210859560112479380
- HaywoodLMcWilliamsDFPearsonCIInflammation and angiogenesis in osteoarthritisArthritis Rheum20034882173217712905470
- DanksLSabokbarAGundleRAthanasouNASynovial macrophage-osteoclast differentiation in inflammatory arthritisAnn Rheum Dis2002611091692112228163
- van der KraanPMVittersELvan de PutteLBvan den BergWBDevelopment of osteoarthritic lesions in mice by “metabolic” and “mechanical” alterations in the knee jointsAm J Pathol19891356100110142556924
- van LentPLBlomABvan derKPCrucial role of synovial lining macrophages in the promotion of transforming growth factor beta-mediated osteophyte formationArthritis Rheum200450110311114730606
- BlomABvan LentPLHolthuysenAESynovial lining macrophages mediate osteophyte formation during experimental osteoarthritisOsteoarthritis Cartilage200412862763515262242
- BlomABBrockbankSMvan LentPLInvolvement of the Wnt signaling pathway in experimental and human osteoarthritis: prominent role of Wnt-induced signaling protein 1Arthritis Rheum200960250151219180479
- BlomABvan LentPLLibregtsSCrucial role of macrophages in matrix metalloproteinase-mediated cartilage destruction during experimental osteoarthritis: involvement of matrix metalloproteinase 3Arthritis Rheum200756114715717195217
- SakaneTTakenoMSuzukiNInabaGBehcet’s diseaseN Engl J Med1999341171284129110528040
- CaneteJDCelisRNoordenbosTDistinct synovial immunopathology in Behcet disease and psoriatic arthritisArthritis Res Ther2009111R1719196489
- AlpsoyEKodeljaVGoerdtSOrfanosCEZouboulisCSerum of patients with Behcet’s disease induces classical (proinflammatory) activation of human macrophages in vitroDermatology2003206322523212673080
- BabanBLiuJYAbdelsayedRMozaffariMSReciprocal relation between GADD153 and Del-1 in regulation of salivary gland inflammation in Sjogren syndromeExp Mol Pathol201395328829724060278
- RoescherNLoddeBMVostersJLTemporal changes in salivary glands of non-obese diabetic mice as a model for Sjogren’s syndromeOral Dis20121819610621914088
- van der VeenBSChenMMullerREffects of p38 mitogen-activated protein kinase inhibition on anti-neutrophil cytoplasmic autoantibody pathogenicity in vitro and in vivoAnn Rheum Dis201170235636521062851
- JiangZJiangJXZhangGXMacrophages: a double-edged sword in experimental autoimmune encephalomyelitisImmunol Lett20141601172224698730
- MironVEBoydAZhaoJWM2 microglia/macrophages drive oligodendrocyte differentiation during CNS remyelinationNat Neurosci20131691211121823872599
- LiuCLiYYuJTargeting the shift from M1 to M2 macrophages in experimental autoimmune encephalomyelitis mice treated with fasudilPLoS One201382e5484123418431
- SavageCOThe evolving pathogenesis of systemic vasculitisClin Med200225458464
- ParameswaranNPatialSTumor necrosis factor-alpha signaling in macrophagesCrit Rev Eukaryot Gene Expr20102028710321133840
- CatrinaAITrollmoCaf KlintEEvidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended reportArthritis Rheum2005521617215641091
- TaylorPCPetersAMPaleologEReduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritisArthritis Rheum2000431384710643698
- CornishALCampbellIKMcKenzieBSChatfieldSWicksIPG-CSF and GM-CSF as therapeutic targets in rheumatoid arthritisNat Rev Rheumatol200951055455919798030
- EhrensteinMREvansJGSinghACompromised function of regulatory t cells in rheumatoid arthritis and reversal by anti-tnfalpha therapyJ Exp Med2004200327728515280421
- GoedkoopAYKraanMCPicavetDIDeactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapyArthritis Res Ther200464R326R33415225368
- NakaharaHSongJSugimotoMAnti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritisArthritis Rheum20034861521152912794819
- SzekaneczZKochAEChemokines and angiogenesisCurr Opin Rheumatol200113320220811333349
- SzekaneczZKochAEMechanism of disease: angiogenesis in inflammatory diseasesNat Clin Pract Rheumatol200731163564317968334
- SinghJABegSLopez-OlivoMATocilizumab for rheumatoid arthritis: a Cochrane systematic reviewJ Rheumatol2011381102020952462
- CampbellIKRichMJBischofRJHamiltonJAThe colony-stimulating factors and collagen-induced arthritis: Exacerbation of disease by m-csf and g-csf and requirement for endogenous m-csfJ Leukoc Biol200068114415010914502
- CookADBraineELCampbellIKRichMJHamiltonJABlockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (gm-csf): Requirement for gm-csf in the effector phase of diseaseArthritis Res20013529329811549370
- AndoWHashimotoJNampeiAImatinib mesylate inhibits osteoclastogenesis and joint destruction in rats with collagen-induced arthritis (CIA)J Bone Miner Metab200624427428216816921
- HamiltonJAColony-stimulating factors in inflammation and autoimmunityNat Rev Immunol20088753354418551128